p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients

Overview of attention for article published in Breast Cancer Research, January 2011

Altmetric Badge

Mentioned by

patent: 2 patents

Readers on

mendeley: 100 Mendeley
citeulike: 1 CiteULike

Summary Patents

So far, Altmetric has seen 2 patents that reference this research output.

RIBOSOMAL RNAS 2'O-METHYLATION AS A NOVEL SOURCE OF BIOMARKERS RELEVANT FOR DIAGNOSIS…

Application WO-2022112578-A1

World Intellectual Property Organisation (WIPO)

DELTA133P53BETA AND DELTA133P53GAMMA ISOFORMS ARE BIOMARKERS OF CANCER STEM CELLS

Application WO-2016120495-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.